The Government has rejected media reports which claim that regulatory approval for Covaxin was rushed due to “political pressure”. New Delhi: The Government has rejected media reports which claim that regulatory approval for Covaxin was rushed due to “political pressure”. The reports claimed that Bharat Biotech, manufacturer of the indigenous...
The post appeared first on .
The Government has rejected media reports which claim that regulatory approval for Covaxin was rushed due to “political pressure”. New Delhi: The Government has rejected media reports which claim that regulatory approval for Covaxin was rushed due to “political pressure”. The reports claimed that Bharat Biotech, manufacturer of the indigenous...
The post appeared first on .
The reports claimed that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine - Covaxin, "had to skip certain processes" and "speed" up clinical trials due to political pressure. The reports further claimed that there were several irregularities in the three phases of the clinical trials conducted for the vaccine.
New Delhi [India], November 7 (ANI/SRV): Motherland Hospital was recently felicitated at the prestigious FE Healthcare Summit Gold Awards in the category of "Best Mother & Childcare Hospital" in North India.
WHO said that four cough and cold syrups might be linked to the deaths of 66 minor children in the Gambia Mumbai: World Health Organization (WHO) said that an Indian pharma company’s allegedly contaminated products have been potentially linked to acute kidney injuries and 66 deaths among children in Gambia,...
The post appeared first on .
New Delhi [India], September 23 (ANI): The devastating COVID-19 pandemic has been a nightmare for the whole world. In fact, India ranks third in terms of the number of total cases and death count.
New Delhi [India], August 17 (ANI): With the country still reporting nearly 10,000 COVID cases daily, Dr VK Paul, Member (Health), NITI Aayog on Wednesday said that the pandemic is still not over while also urging the citizens to increase the rate of vaccination of the precaution dose among the population.
Hyderabad (Telangana) [India], August 11 (ANI): The recently approved heterologous Covid-19 vaccine, Corbevax is expected to be available as a booster dose on the COWIN App in both public and private vaccination centres from Friday, manufacturer Biological E. Limited (BE) said.
New Delhi [India], August 10 (ANI): Union Health Secretary Rajesh Bhushan on Wednesday said that the Centre has approved Biological E's Corbevax as a precaution dose after completion of six months from the date of administration of the second dose of either Covaxin or Covishield vaccines for the population above 18 years.
New Delhi [India], August 10 (ANI): The Central government has approved Biological E's Corbevax for restricted use in an emergency as a heterologous booster dose, official sources confirmed on Wednesday.